Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.

Saved in:

Bibliographic Details
Title:	Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.
Authors:	Bohn KA; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, AmarilloTX, USA.; Department of Pharmaceutical Sciences, College of Pharmacy, Harding University, SearcyAR, USA., Adkins CE; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, AmarilloTX, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University Health Sciences Center, MorgantownWV, USA.; Department of Pharmaceutical Sciences, South University, SavannahGA, USA., Nounou MI; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, AmarilloTX, USA.; Department of Pharmaceutical Sciences, Appalachian College of Pharmacy, OakwoodVA, USA.; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria UniversityAlexandria, Egypt.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Saint Joseph, HartfordCT, USA., Lockman PR; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, AmarilloTX, USA.
Source:	Frontiers in pharmacology [Front Pharmacol] 2017 Apr 11; Vol. 8, pp. 193. Date of Electronic Publication: 2017 Apr 11 (Print Publication: 2017).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2017.00193